Medtronic today announced data demonstrating improved outcomes with its implantable cardioverter defibrillators (ICDs). ICDs treat dangerously fast or irregular heart rhythms — ventricular tachycardia or ventricular fibrillation — that can lead to sudden cardiac death (SCD). Two analyses demonstrated survival benefits and a reduction in life-threatening cardiac events with the use of ICDs. Data provided […]
ICD
Medtronic has a serious recall of ICDs and CRT-Ds
FDA has issued a Class I designation of a Medtronic (NYSE: MDT) recall involving 239,171 ICDs and CRT-Ds with potential battery life problems. The agency reported 444 complaints regarding the devices: Evera, Viva, Brava, Claria, Amplia, Compia, and Visia implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-Ds) distributed from Aug. 31, 2012, to May […]
How Abbott is making good on investor promises
Abbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year. The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ […]
9 cardiology breakthroughs you need to know
Cardiology breakthroughs couldn’t come soon enough because heart disease is the No. 1 killer of men and women in the U.S. About 610,000 Americans die of heart disease per year, and an additional 735,000 Americans suffer from a heart attack. The statistics terrify. About 610,000 Americans die of heart disease per year, and an additional […]
